Crossmark

Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response

Crossref DOI link: https://doi.org/10.1186/s13045-020-00993-0

Published Online: 2020-11-25

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beider, Katia

Rosenberg, Evgenia

Dimenshtein-Voevoda, Valeria

Sirovsky, Yaarit

Vladimirsky, Julia

Magen, Hila

Ostrovsky, Olga

Shimoni, Avichai

Bromberg, Zohar

Weiss, Lola

Peled, Amnon

Nagler, Arnon https://orcid.org/0000-0002-0763-1265
License Information

Text and Data Mining valid from 2020-11-25

Version of Record valid from 2020-11-25
More Information

Article History

Received: 27 July 2020

Accepted: 9 November 2020

First Online: 25 November 2020

Ethics approval and consent to participate

: The study was approved by Institutional Review Board of the Sheba Medical Center. Animal experiments were approved by the Animal Care Committee of the Hebrew University, Jerusalem.

: Not applicable.

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below